"AI/Radiomics 2.0: How to Safely Translate Research Results to the Clinics"
Nickolas Papanikolaou, Computational Clinical Imaging Group
"A New Society of Mind"
Joe Paton, Learning Lab
Moderation
Carlos Minutti, Immunoregulation Lab
Venue
Champalimaud Foundation Auditorium
Champalimaud Open Seminar (COpS)
"Exploring the Crosstalk between the Tumour-Intrinsic & Extrinsic Drivers of Cancer"
Adriana Sánchez-Danés, Cancer and Stem Cell Biology Lab
"How Neural Circuits Compute"
Christian Machens, Theoretical Neuroscience Lab
Moderation
Henrique Veiga-Fernandes, Immunophysiology Lab
Champalimaud Open Seminars: Carlos Minutti
Date and time:
20 January 2025 – 12:00
Location:
Champalimaud Foundation Auditorium
Description:
Conventional Dendritic Cells – Ecology, Diversity, and Functio
Carlos Minutti (Immunoregulation Lab)
Moderator: Cristina João (Myeloma Lymphoma Research Group)
Champalimaud Open Seminar: Gonzalo de Polavieja and Mireia Castillo-Martin
Date and time:
18 November 2024 – 12:00
Location:
Champalimaud Foundation Auditorium
Description:
The Roles of AI in Scientific Discovery: Our Experience Studying Collective Behavio
Gonzalo de Polavieja (Mathematics of Behavior and Intelligence Lab)
Molecular Characterization of Cancer by Spatial Pathology
Mireia Castillo-Martin (Molecular and Experimental Pathology Lab)
Moderator: Ana Luísa Correia (Cancer Dormancy and Immunity Lab)
Champalimaud Open Seminar: Miguel Seabra and Pedro Gouveia
Date and time:
6 May 2024 – 12:00
Location:
Champalimaud Foundation Auditorium
Description:
Low Cost Ocular Gene Therapy: Bridging Technology with Public Health
Miguel Seabra (Ocular Low-Cost Gene Therapy)
An Unexpected Immersive Breast Cancer Journey
Pedro Gouveia (Digital Surgery)
Moderator: Alfonso Renart (Circuit Dynamics & Computation)
Vision to Victory: Lessons from CellmAbs’ Journey in Biotech Innovation
Description
Nuno Prego Ramos, co-founder and CEO of CellmAbs, will share the journey of CellmAbs, from it's early days starting with an initial technology from NOVA University to becoming a pioneering force in cancer therapy innovation.
In this talk, we will hear about the strategic decisions, challenges and breakthroughs that propelled the company to its selling the assets to the pharmaceutical giant, BioNTech.
Unpacking bias: perspectives from neuroscience and social psychology
We make countless decisions each hour, each minute. Most of these decisions are made without our active awareness and while they may be inconsequential to us, they can impact other people. For instance, when we choose a seat on the train next to people who look most similar to ourselves or how much eye contact we make (or don’t make).
Tripping into the (un)known: treating the mind with psychedelics
For millennia, humans have “tripped” on psychedelic substances for spiritual growth, healing or recreational purposes. Today, the healthcare community has renewed interest in the potential of psychedelics for mental health.
In this Ar event, Tiago Quendera and Tatiana Silva, two neuroscience PhD students at the Champalimaud Centre for the Unknown, will take you through the ups and downs of the history of psychedelics and their use in research.
CCU Clinical Seminar
Alexandra Borges, MD Radiologist, AMA accredited fellowship in Neuroradiology at UCLA,
PhD student from “Programa de formação médica avançada” (PFMA) 2nd edition
Title:
MR based biomarkers of treatment response to anti-VEGF mAb and their genomic correlates in a mouse model of High-Grade-Gliomas (HGG)
